KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Merck (MRK) Return on Equity (2016 - 2025)

Merck (MRK) has disclosed Return on Equity for 17 consecutive years, with 0.38% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Equity rose 10.0% to 0.38% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.38%, a 10.0% increase, with the full-year FY2024 number at 0.41%, up 40.0% from a year prior.
  • Return on Equity was 0.38% for Q3 2025 at Merck, up from 0.34% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.38% in Q3 2025 to a low of 0.07% in Q2 2023.
  • A 5-year average of 0.14% and a median of 0.06% in 2024 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: fell -23bps in 2021, then soared 40bps in 2024.
  • Merck's Return on Equity stood at 0.02% in 2021, then plummeted by -107bps to 0.0% in 2022, then skyrocketed by 877bps to 0.01% in 2023, then skyrocketed by 3510bps to 0.38% in 2024, then increased by 0bps to 0.38% in 2025.
  • Per Business Quant, the three most recent readings for MRK's Return on Equity are 0.38% (Q3 2025), 0.34% (Q2 2025), and 0.37% (Q1 2025).